Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Lagi

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|May 3, 2021
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, et al.
Andrology|December 10, 2021
Male reproductive system inflammation after healing from coronavirus disease 2019Simone Morselli, Arcangelo Sebastianelli, Andrea Liaci, et al.
International Journal of Antimicrobial Agents|February 9, 2023
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSITheodossis Papavramidis, Ivan Gentile, Anna Maria Cattelan, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Journal of Medical Virology|December 29, 2025
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)Filippo Lagi, Giuseppe Formica, Massimiliano Fabbiani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary StudyAlessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, et al.
AIDS Research and Treatment|October 6, 2025
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple RegimenPaolo Maggi, Addolorata Masiello, Barbara Menzaghi, et al.
Viruses|April 27, 2024
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA StudyNicolò Corti, Barbara Menzaghi, Giancarlo Orofino, et al.
Viruses|February 28, 2023
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)Tommaso Manciulli, Michele Spinicci, Barbara Rossetti, et al.
Journal of Clinical Medicine|April 3, 2021
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent <i>Clostridioides difficile</i> InfectionsGuido Granata, Nicola Petrosillo, Lucia Adamoli, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|May 3, 2021
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, et al.
Andrology|December 10, 2021
Male reproductive system inflammation after healing from coronavirus disease 2019Simone Morselli, Arcangelo Sebastianelli, Andrea Liaci, et al.
International Journal of Antimicrobial Agents|February 9, 2023
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSITheodossis Papavramidis, Ivan Gentile, Anna Maria Cattelan, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Journal of Medical Virology|December 29, 2025
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)Filippo Lagi, Giuseppe Formica, Massimiliano Fabbiani, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary StudyAlessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, et al.
AIDS Research and Treatment|October 6, 2025
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple RegimenPaolo Maggi, Addolorata Masiello, Barbara Menzaghi, et al.
Viruses|April 27, 2024
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA StudyNicolò Corti, Barbara Menzaghi, Giancarlo Orofino, et al.
Viruses|February 28, 2023
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)Tommaso Manciulli, Michele Spinicci, Barbara Rossetti, et al.
Journal of Clinical Medicine|April 3, 2021
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent <i>Clostridioides difficile</i> InfectionsGuido Granata, Nicola Petrosillo, Lucia Adamoli, et al.
Pageof 9